Evidence map›Paper›PMID 33513496›Full record

ArticleThe Science of the total environment2021

The detection and stability of the SARS-CoV-2 RNA biomarkers in wastewater influent in Helsinki, Finland.

Anna-Maria Hokajärvi, Annastiina Rytkönen, Ananda Tiwari, Ari Kauppinen, Sami Oikarinen, Kirsi-Maarit Lehto, Aino Kankaanpää, Teemu Gunnar, Haider Al-Hello, Soile Blomqvist and 3 more

Abstract read
In one paragraph

Article in The Science of the total environment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Patterns of SARS-CoV-2 circulation revealed by a nationwide sewage surveillance programme, the Netherlands, August 2020 to February 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anna-Maria HokajärviFinnish Institute for Health and Welfare, Expert Microbiology Unit, Kuopio, Finland.
Annastiina RytkönenFinnish Institute for Health and Welfare, Expert Microbiology Unit, Kuopio, Finland.
Ananda TiwariFinnish Institute for Health and Welfare, Expert Microbiology Unit, Kuopio, Finland.
Ari KauppinenFinnish Institute for Health and Welfare, Expert Microbiology Unit, Kuopio, Finland.
Sami OikarinenTampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
Kirsi-Maarit LehtoTampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
Aino KankaanpääFinnish Institute for Health and Welfare, Forensic Toxicology Unit, Helsinki, Finland.
Teemu GunnarFinnish Institute for Health and Welfare, Forensic Toxicology Unit, Helsinki, Finland.
Haider Al-HelloFinnish Institute for Health and Welfare, Expert Microbiology Unit, Helsinki, Finland.
Soile BlomqvistFinnish Institute for Health and Welfare, Expert Microbiology Unit, Helsinki, Finland.
Ilkka T MiettinenFinnish Institute for Health and Welfare, Expert Microbiology Unit, Kuopio, Finland.
Carita Savolainen-KopraFinnish Institute for Health and Welfare, Expert Microbiology Unit, Helsinki, Finland.
Tarja PitkänenFinnish Institute for Health and Welfare, Expert Microbiology Unit, Kuopio, Finland; University of Helsinki, Faculty of Veterinary Medicine, Dept. Food Hygiene and Environmental Health, Finland. Electronic address: tarja.pitkanen@thl.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wastewater-based surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is used to monitor the population-level prevalence of the COVID-19 disease. In many cases, due to lockdowns or analytical delays, the analysis of wastewater samples might only be possible after prolonged storage. In this study, the effect of storage conditions on the RNA copy numbers of the SARS-CoV-2 virus in wastewater influent was studied and compared to the persistence of norovirus over time at 4 °C, -20 °C, and -75 °C using the reverse-transcription quantitative PCR (RT-qPCR) assays E-Sarbeco, N2, and norovirus GII. For the first time in Finland, the presence of SARS-CoV-2 RNA was tested in 24 h composite influent wastewater samples collected from Viikinmäki wastewater treatment plant, Helsinki, Finland. The detected and quantified SARS-CoV-2 RNA copy numbers of the wastewater sample aliquots taken during 19-20 April 2020 and stored for 29, 64, and 84 days remained surprisingly stable. In the stored samples, the SARS betacoronavirus and SARS-CoV-2 copy numbers, but not the norovirus GII copy numbers, seemed slightly higher when analyzed from the pre-centrifuged pellet-that is, the particulate matter of the influent-as compared with the supernatant (i.e., water fraction) used for ultrafiltration, although the difference was not statistically significant. Furthermore, when wastewater was spiked with SARS-CoV-2, linear decay at 4 °C was observed on the first 28 days, while no decay was visible within 58 days at -20 °C or -75 °C. In conclusion, freezing temperatures should be used for storage when immediate SARS-CoV-2 RNA analysis from the wastewater influent is not possible. Analysis of the particulate matter of the sample, in addition to the water fraction, can improve the detection frequency.

Indexed as

COVID-19SARS-CoV-2BiomarkersCommunicable Disease ControlFinlandHumansRNA, ViralWastewaterBiomarkersRNA, ViralWastewaterDecay characteristicsMunicipal sewageNew coronavirusStorage conditions

Identifiers

PMID33513496
PMCPMC7825999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.